원익
032940KOSDAQ59.8 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Wonyeong operates in four business segments: Electronics Components, General Merchandise, Healthcare, and Others, offering a diverse range of products including HIC production, quartz glass, medical devices, and medical cosmetics. Key clients include global companies like Honeywell and Lumenis, with medical cosmetics accounting for approximately 57% of 2024 sales.
Number of Employees
96people
Average Salary
60.6M KRW
Score Calculation Basis
Detailed Financial Score
Higher than industry avg (caution)
Lower than industry avg (good)
Below industry avg
Half of industry avg (excellent)
Avg ▲7.7% (2-year basis)
Avg ▼14.8% (2-year basis)
Avg ROE 3.7% (improving, 3yr)
Detailed News Sentiment
- Negative[거버넌스워치] 케어랩스 자회사 굿닥 부실 늪 ‘허우적’
케어랩스의 재무 악화로 인해 원익 계열 기업의 부정적 영향이 예상됨.
- Neutral원익그룹, “1,363억원은 이연법인세자산” 주장… 공시엔 “이연법인....
원익그룹의 재무제표 정정 관련 논란으로 인해 구체적인 주식 영향이 명확하지 않아 중립적 평가.
- Neutral아빠 돈 빌려 아빠 주식 사고, 아빠회사 자사주 차익으로 갚아…원익.....
The news focuses on internal financial maneuvers within the Wonik Group without direct impact on stock performance.
Detailed Momentum
52w mid range (51%)
1m +73.20% (strong rise)
Volume surge
Detailed Disclosure
- Neutral대규모기업집단현황공시[분기별공시(개별회사용)]2026-08-28
- Negative지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항2026-08-14
- Neutral반기보고서 (2026.06)2026-08-14
